News Notification

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

60 views Tags: CME Brigham Board Review

Elevate Your Hematology and Oncology

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology is a case-based online CME course focused on improving overall knowledge and clinical competency. Prep for your board exam and stay current on basic principles, changing guidelines and therapeutic strategies. Practice improvement areas featured in the continuing medical education program include:

  • Acquired/Congenital Bone Marrow Failure
  • Thalassemia/Hemoglobinopathies
  • Transfusion Medicine
  • New Therapies (Pharmacology)
  • Infections of the Immunocompromised
  • Hematologic Malignancies (Acute/Chronic Leukemias; Myeloma/Lymphomas)
  • Thoracic Oncology (Head/Neck/Lung/Thyroid)
  • and many more…

* Date of Original Release: June 30, 2022

* Termination Date: June 30, 2025

Learning Objectives

At the conclusion of this activity, the participant will be able to:

  • Apply current/recommended hematology and oncology guidelines in clinical practice
  • Perform differential diagnosis of complex clinical presentations related to hematologic and oncologic disorders
  • Identify/apply current therapeutic options for specific hematologic and oncologic disorders
  • Review and interpret up-to-date literature relevant to clinical practice in hematology and oncology
  • Demonstrate knowledge of pathophysiology as it applies to management of hematology and oncology disorders
  • Apply knowledge gained to the ABIM certification/recertification hematology and oncology examinations


0 0 votes
Article Rating


1. Molecular Genetics of Cancer – Nikhil Wagle, MD

2. Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD

3. Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD

4. Infections in Cancer Patients – Lindsey Baden, MD

5. Symptom Management in Patients with Cancer – Andrew J. Lawton, MD

6. Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD, MS, FAAHPM, AGSF

7. Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD

8. Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD

9. Acute Leukemias – Daniel J. DeAngelo, MD, PhD

10. Myelodysplastic Syndrome – Eric S. Winer, MD

11. Chronic Myelogenous Leukemia – Marlise R. Luskin, MD

12. Myeloproliferative Syndromes – Ann M. Mullally, MD

13. Multiple Myeloma – Kenneth C. Anderson, MD

14. Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD

15. Low Grade Lymphomas – Caron A. Jacobson, MD

16. Aggressive Non-Hodgkin Lymphoma – Eric D. Jacobsen, MD

17. Hodgkin’s Lymphoma – Reid W. Merryman, MD

18. Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD

19. Head and Neck Cancer – Robert I. Haddad, MD

20. Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD

21. Management of Stage I-III Non Small Cell Lung Cancer – Mark Awad, MD, PhD

22. Management of Metastatic Non Small Cell Lung Cancer – Mark Awad, MD, PhD

23. Mesothelioma and Thymoma – David M. Jackman, MD

24. Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD

25. Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD

26. Pancreatic Cancer – Brian M. Wolpin, MD

27. Hepatobiliary Cancer – James M. Cleary, MD, PhD

28. Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD

29. Colorectal Cancers Part 2 – Robert J. Mayer, MD

30. Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD

31. Testicular Cancer – Mark M. Pomerantz, MD

32. Renal and Bladder Cancer – Guru P. Sonpavde, MBBS

33. Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD

34. Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD

35. Melanoma – F. Stephen Hodi, MD

36. Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD

37. Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD

38. Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD

39. Neuro-oncology – David A. Reardon, MD

40. Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH

41. Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD

42. Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD

43. Management of Metastatic Breast Cancer – Adrienne G. Waks, MD

44. Breast Cancer Survivorship – Ann H. Partridge, MD, MPH

45. Hematopoiesis and Cytokines – David T. Scadden, MD

46. Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD

47. Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD

48. Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD

49. Anemia – An Overview – Robert Stern, MD

50. Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD

51. Immune Hemolytic Anemia – Richard M. Kaufman, MD

52. Non-immune Hemolytic Anemia – David E. Golan, PhD, MD

53. Sickle Cell Disease – Maureen M. Achebe, MD, MPH

54. Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD

55. Disorders of Neutrophils – Nancy Berliner, MD

56. Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD

57. Hemophilia – Aric D. Parnes, MD

58. Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH

59. Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD

60. Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD

61. Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Notify of
Inline Feedbacks
View all comments
error: Content is protected !!